{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:14:30Z","timestamp":1649024070420},"reference-count":31,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1620\/tjem.231.1","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T23:06:53Z","timestamp":1377558413000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Vaccination with Plasmid DNA Encoding a Mutant Toxic Shock Syndrome Toxin-1 Ameliorates Toxin-induced Lethal Shock in Mice"],"prefix":"10.1620","volume":"231","author":[{"given":"Mao-Hui","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Oncology Surgery, Zhongnan Hospital, Wuhan University"},{"name":"Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Chun","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Bio-Engineering, Dalian Nationalities University"},{"name":"Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nakane","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Liang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine"},{"name":"Department of Zoonoses, Kitasato University School of Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Allard, M., Ster, C., Jacob, C.L., Scholl, D., Diarra, M.S., Lacasse, P. &amp; Malouin, F. (2013) The expression of a putative exotoxin and an ABC transporter during bovine intramammary infection contributes to the virulence of <i>Staphylococcus aureus<\/i>. <i>Vet. Microbiol.<\/i>, 162, 761-770.","DOI":"10.1016\/j.vetmic.2012.09.029"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bavari, S., Dyas, B. &amp; Ulrich, R.G. (1996) Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. <i>J. Infect. Dis.<\/i>, 174, 338-345.","DOI":"10.1093\/infdis\/174.2.338"},{"key":"3","unstructured":"Bavari, S., Ulrich, R.G. &amp; LeClaire, R.D. (1999) Cross-reactive antibodies prevent the lethal effects of <i>Staphylococcus aureus<\/i> superantigens. <i>J. Infect. Dis.<\/i>, 180, 1365-1369."},{"key":"4","unstructured":"Bohach, G.A., Hovde, C.J., Handley, J.P. &amp; Schlievert, P.M. (1988) Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. <i>Infect. Immun.<\/i>, 56, 400-404."},{"key":"5","unstructured":"Bonventre, P.F., Heeg, H., Edwards, C.K. &amp; Cullen, C.M. (1995) A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. <i>Infect. Immun.<\/i>, 63, 509-515."},{"key":"6","unstructured":"Cui, J.C., Hu, D.L., Lin, Y.C., Qian, A.D. &amp; Nakane, A. (2005) Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against <i>Staphylococcus aureus<\/i> infection. <i>FEMS Immunol. Med. Microbiol.<\/i>, 45, 45-51."},{"key":"7","unstructured":"Cullen, C.M., Blanco, L.R., Bonventre, P.F. &amp; Choi, E. (1995) A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation. <i>Infect. Immun.<\/i>, 63, 2141-2146."},{"key":"8","unstructured":"Dinges, M.M., Orwin, P.M. &amp; Schlievert, P.M. (2000) Exotoxins of <i>Staphylococcus aureus<\/i>. <i>Clin. Microbiol. Rev.<\/i>, 13, 16-34."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Etz, H., Minh, D.B., Henics, T., Dryla, A., Winkler, B., Triska, C., Boyd, A.P., Sollner, J., Schmidt, W., von Ahsen, U., Buschle, M., Gill, S.R., Kolonay, J., Khalak, H., Fraser, C.M, von Gabain, A., Nagy, E. &amp; Meinke, A. (2002) Identification of in vivo expressed vaccine candidate antigens from <i>Staphylococcus aureus<\/i>. <i>Proc. Natl. Acad. Sci. USA<\/i>, 99, 6573-6578.","DOI":"10.1073\/pnas.092569199"},{"key":"10","unstructured":"Fitzgerald, J.R., Monday, S.R., Foster, T.J., Bohach, G.A., Hartigan, P.J., Meaney, W.J. &amp; Smyth, C.J. (2001) Characterization of a putative pathogenicity island from bovine <i>Staphylococcus aureus<\/i> encoding multiple superantigens. <i>J. Bacteriol.<\/i>, 183, 63-70."},{"key":"11","unstructured":"Foster, A.P. (2012) Staphylococcal skin disease in livestock. <i>Vet. Dermatol.<\/i>, 23, 342-351."},{"key":"12","doi-asserted-by":"crossref","unstructured":"Gampfer, J., Thon, V., Gulle, H., Wolf, H.M. &amp; Eibl, M.M. (2002) Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. <i>Vaccine<\/i>, 20, 1354-1364.","DOI":"10.1016\/S0264-410X(01)00470-4"},{"key":"13","unstructured":"Hu, D.L., Omoe, K., Narita, K., Cui, J.C., Shinagawa, K. &amp; Nakane, A. (2006) Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against <i>Staphylococcus aureus<\/i> infection. <i>Microbes Infect.<\/i>, 8, 2841-2848."},{"key":"14","unstructured":"Hu, D.L., Omoe, K., Sasaki, S., Sashinami, H., Sakuraba, H., Yokomizo, Y., Shinagawa, K. &amp; Nakane, A. (2003) Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against <i>Staphylococcus aureus<\/i> infection. <i>J. Infect. Dis.<\/i>, 188, 743-752."},{"key":"15","unstructured":"Jarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne, J. &amp; Vandenesch, F. (2002) Relationships between <i>Staphylococcus aureus<\/i> genetic background, virulence factors, <i>agr<\/i> groups (alleles), and human disease. <i>Infect. Immun.<\/i>, 70, 631-641."},{"key":"16","unstructured":"Jupin, C., Anderson, S., Damais, C., Alouf, J.E. &amp; Parant, M. (1988) Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. <i>J. Exp. Med.<\/i>, 167, 752-761."},{"key":"17","unstructured":"Kotzin, B.L., Leung, D.Y., Kappler, J. &amp; Marrack, P. (1993) Superantigens and their potential role in human disease. <i>Adv. Immunol.<\/i>, 54, 99-166."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kum, W.W. &amp; Chow, A.W. (2001) Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. <i>J. Infect. Dis.<\/i>, 183, 1739-1748.","DOI":"10.1086\/320732"},{"key":"19","unstructured":"LeClaire, R.D., Hunt, R.E. &amp; Bavari, S. (2002) Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. <i>Infect. Immun.<\/i>, 70, 2278-2281."},{"key":"20","unstructured":"Maree, C.L., Daum, R.S., Boyle-Vavra, S., Matayoshi, K. &amp; Miller, L.G. (2007) Community-associated methicillin-resistant <i>Staphylococcus aureus<\/i> isolates causing healthcare-associated infections. <i>Emerg. Infect. Dis.<\/i>, 13, 236-242."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Marrack, P. &amp; Kappler, J. (1990) The staphylococcal enterotoxins and their relatives. <i>Science<\/i>, 248, 705-711.","DOI":"10.1126\/science.2185544"},{"key":"22","unstructured":"Michie, C.A. (2002) Staphylococcal vaccines. <i>Trends Immunol.<\/i>, 23, 461-463."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Musser, J.M., Schlievert, P.M., Chow, A.W., Ewan, P., Kreiswirth, B.N., Rosdahl, V.T., Naidu, A.S., Witte, W. &amp; Selander, R.K. (1990) A single clone of <i>Staphylococcus aureus<\/i> causes the majority of cases of toxic shock syndrome. <i>Proc. Natl. Acad. Sci. USA<\/i>, 87, 225-229.","DOI":"10.1073\/pnas.87.1.225"},{"key":"24","unstructured":"Nakane, A., Okamoto, M., Asano, M., Kohanawa, M. &amp; Minagawa, T. (1995) Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in <i>Staphylococcus aureus<\/i> infection in mice. <i>Infect. Immun.<\/i>, 63, 1165-1172."},{"key":"25","unstructured":"Narita, K., Hu, D.L., Tsuji, T. &amp; Nakane, A. (2008) Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against <i>Staphylococcus aureus<\/i> infection. <i>FEMS Immunol. Med. Microbiol.<\/i>, 52, 389-396."},{"key":"26","unstructured":"Nilsson, I.M., Verdrengh, M., Ulrich, R.G., Bavari, S. &amp; Tarkowski, A. (1999) Protection against <i>Staphylococcus aureus<\/i> sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. <i>J. Infect. Dis.<\/i>, 180, 1370-1373."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Schlievert, P.M. (2001) Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. <i>J. Allergy Clin. Immunol.<\/i>, 108, S107-110.","DOI":"10.1067\/mai.2001.117820"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Sheen, T.R., Cavaco, C.K., Ebrahimi, C.M., Thoman, M.L., Sanderson, S.D., Morgan, E.L. &amp; Doran, K.S. (2011) Control of methicillin resistant <i>Staphylococcus aureus<\/i> infection utilizing a novel immunostimulatory peptide. <i>Vaccine<\/i>, 30, 9-13.","DOI":"10.1016\/j.vaccine.2011.10.054"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Spaulding, A.R., Lin, Y.C., Merriman, J.A., Brosnahan, A.J., Peterson, M.L. &amp; Schlievert, P.M. (2012) Immunity to <i>Staphylococcus aureus<\/i> secreted proteins protects rabbits from serious illnesses. <i>Vaccine<\/i>, 30, 5099-5109.","DOI":"10.1016\/j.vaccine.2012.05.067"},{"key":"30","unstructured":"Stiles, B.G., Garza, A.R., Ulrich, R.G. &amp; Boles, J.W. (2001) Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. <i>Infect. Immun.<\/i>, 69, 2031-2036."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ulrich, R.G., Olson, M.A. &amp; Bavari, S. (1998) Development of engineered vaccines effective against structurally related bacterial superantigens. <i>Vaccine<\/i>, 16, 1857-1864.","DOI":"10.1016\/S0264-410X(98)00176-5"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/231\/1\/231_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:55:30Z","timestamp":1619639730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/231\/1\/231_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.231.1","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}